P38MAPK signaling enhances glycolysis through the up-regulation of the glucose transporter GLUT-4 in gastric cancer cells

Cellular Physiology and Biochemistry

Volumn 36, Issue 1, 2015, Pages 155-165

  Liu, Jingjing ^a   Wen, Dacheng ^a   Fang, Xuedong ^b   Wang, Xudong ^a   Liu, Tianzhou ^a   Zhu, Jiaming ^a  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Gastric cancer; Glucose transporter (GLUT) 4; Glycolysis; p38MAPK signaling

Indexed keywords

GLUCOSE TRANSPORTER 4; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA; MAP2K6 PROTEIN, HUMAN; MEF2A PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MYOCYTE ENHANCER FACTOR 2; PHOSPHOPROTEIN PHOSPHATASE 2; SLC2A4 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CANCER TISSUE; CELL GROWTH; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GASTRIC CANCER CELL LINE; GENE MUTATION; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUCIFERASE ASSAY; MTT ASSAY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; TRANSIENT TRANSFECTION; UPREGULATION; WESTERN BLOTTING; CELL PROLIFERATION; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; STOMACH TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; GLUCOSE TRANSPORTER TYPE 4; GLYCOLYSIS; HUMANS; MAP KINASE KINASE 6; MAP KINASE SIGNALING SYSTEM; MEF2 TRANSCRIPTION FACTORS; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; STOMACH NEOPLASMS;

EID: 84928719172     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000374060     Document Type: Article

References (29)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-2917.
2. Takahashi T, Saikawa Y, Kitagawa Y: Gastric cancer: current status of diagnosis and treatment. Cancers (Basel) 2013;5:48-63.
3. Yang L: Incidence and mortality of gastric cancer in China. World J Gastroenterol 2006;12:17-20.
4. Zhu X, Li J: Gastric carcinoma in China: Current status and future perspectives (Review). Oncol Lett 2010;1:407-412.
5. Alberts SR, Cervantes A, van de Velde CJ: Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 2003;14:S ii31-36.
6. Jang BC, Sanchez T, Schaefers HJ, Trifan OC, Liu CH, Creminon C, Huang CK, Hla T: Serum withdrawalinduced post-transcriptional stabilization of cyclooxygenase-2 mRNA in MDA-MB-231 mammary carcinoma cells requires the activity of the p38 stress-activated protein kinase. J Biol Chem 2000;275:39507-39515.
7. Kumar B, Koul S, Petersen J, Khandrika L, Hwa JS, Meacham RB, Wilson S, Koul HK: p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-8 activity. Cancer Res 2010;70:832-841.
8. Hsieh YH, Wu TT, Huang CY, Hsieh YS, Hwang JM, Liu JY: p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells. Cancer Res 2007;67:4320-4327.
9. Huang Q, Lan F, Wang X, Yu Y, Ouyang X, Zheng F, Han J, Lin Y, Xie Y, Xie F, Liu W, Yang X, Wang H, Dong L, Wang L, Tan J: IL-1beta-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9. Mol Cancer 2014;13:18.
10. Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell 2011;144:646-674.
11. Warburg O: On the origin of cancer cells. Science 1956;123:309-314.
12. Warburg O: On respiratory impairment in cancer cells. Science 1956;124:269-270.
13. Liang B, Wang S, Zhu XG, Yu YX, Cui ZR, Yu YZ: Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer. World J Gastroenterol 2005;11:623-628.
14. Thai MV, Guruswamy S, Cao KT, Pessin JE, Olson AL: Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes. J Biol Chem 1998;273:14285-14292.
15. Zheng S, Rollet M, Pan YX: Protein restriction during gestation alters histone modifications at the glucose transporter 4 (GLUT4) promoter region and induces GLUT4 expression in skeletal muscle of female rat offspring. J Nutr Biochem 2012;23:1064-1071.
16. Johnson GL, Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002;298:1911-1912.
17. Kwon CH, Moon HJ, Park HJ, Choi JH, Park do Y: S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-kappaB activation in gastric cancer cells. Mol Cells 2013;35:226-234.
18. Chen W, Wang Z, Jiang C, Ding Y: PP2A-Mediated Anticancer Therapy. Gastroenterol Res Pract 2013;2013:675429.
19. Wera S, Hemmings BA: Serine/threonine protein phosphatases. Biochem J 1995;311:17-29.
20. Janssens V, Goris J: Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 2001;353:417-439.
21. Virshup DM: Protein phosphatase 2A: a panoply of enzymes. Curr Opin Cell Biol 2000;12:180-185.
22. Westermarck J, Hahn WC: Multiple pathways regulated by the tumor suppressor PP2A in transformation. Trends Mol Med 2008;14:152-160.
23. Law AH, Tam AH, Lee DC, Lau AS: A Role for Protein Phosphatase 2A in Regulating p38 Mitogen Activated Protein Kinase Activation and Tumor Necrosis Factor-Alpha Expression during Influenza Virus Infection. Int J Mol Sci 2013;14:7327-7340.
24. Zador S: Correspondence re: Ito T, Noguchi Y, Satoh S, Hayashi H, Inayama Y, Kitamura H: Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage. Mod Pathol 1998; 11:437-443.
25. Mod Pathol 1998;11:1146.
26. Shibata K, Kajiyama H, Ino K, Nawa A, Nomura S, Mizutani S, Kikkawa F: P-LAP/IRAP-induced cell proliferation and glucose uptake in endometrial carcinoma cells via insulin receptor signaling. BMC Cancer 2007;7:15.
27. Noguchi Y, Marat D, Saito A, Yoshikawa T, Doi C, Fukuzawa K, Tsuburaya A, Satoh S, Ito T: Expression of facilitative glucose transporters in gastric tumors. Hepatogastroenterology 1999;46:2683-2689.
28. Molkentin JD, Black BL, Martin JF, Olson EN: Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 1995;83:1125-1136.
29. Molkentin JD, Olson EN: Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc Natl Acad Sci USA 1996;93:9366-9373.